Immunogenicity assessment of Ovaleap (R) (XM17) recombinant human follicle-stimulating hormone in infertile women undergoing assisted reproductive technology (ART)

被引:0
|
作者
Zou, L. [1 ]
Mueller, A. [2 ]
Gertz, B. [2 ]
Weiss, H. [3 ]
Liu, P. [1 ]
机构
[1] Teva Pharmaceut, Global Bioassays & Technol, W Chester, PA USA
[2] Merckle GmbH, Teva Grp, Ulm, Germany
[3] Teva Global Med Affairs, Petah Tiqwa, Israel
来源
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:233 / 233
页数:1
相关论文
共 50 条
  • [21] Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone
    Esposito, MA
    Barnhart, KT
    Coutifaris, C
    Patrizio, P
    [J]. FERTILITY AND STERILITY, 2001, 75 (03) : 519 - 524
  • [22] Follicular and other characteristics with Ovaleap (R) (follitropin alfa) in a phase 3 study of infertile women using assisted reproductive technology (ART)
    Mueller, A.
    Kuczynski, W.
    Weiss, H.
    Bias, P.
    [J]. GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2015, 37 (04): : 170 - 170
  • [23] Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-α (Gonal-F®) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology
    Moon, Shin Yong
    Choi, Young Sik
    Ku, Seung-Yup
    Kim, Seok Hyun
    Choi, Young Min
    Kang, Inn Soo
    Kim, Chung Hoon
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2007, 33 (03) : 305 - 315
  • [24] Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies
    Kelly, E
    [J]. FERTILITY AND STERILITY, 2003, 80 (05) : 1105 - 1107
  • [25] Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
    Philippe Lehert
    Efstratios M Kolibianakis
    Christos A Venetis
    Joan Schertz
    Helen Saunders
    Pablo Arriagada
    Samuel Copt
    Basil Tarlatzis
    [J]. Reproductive Biology and Endocrinology, 12
  • [26] Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
    Lehert, Philippe
    Kolibianakis, Efstratios M.
    Venetis, Christos A.
    Schertz, Joan
    Saunders, Helen
    Arriagada, Pablo
    Copt, Samuel
    Tarlatzis, Basil
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2014, 12
  • [27] Acceptability and utility of the CONSORT algorithm for calculating recombinant human follicle-stimulating hormone starting doses for ovarian stimulation in assisted reproductive technology: an observational study
    Pouly, J.
    Olivennes, F.
    Massin, N.
    Celle, M.
    Caizergues, N.
    [J]. HUMAN REPRODUCTION, 2013, 28 : 355 - 356
  • [28] Recombinant human follicle-stimulating hormone (r-hFSH) versus human menopausal gonadotrophins (u-hMG) for the induction of superovulation in women undergoing IUI
    Allahbadia, GN
    [J]. FIRST WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (FREE PAPERS), 1999, : 3 - 9
  • [29] EFFECTIVENESS OF RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (R-HFSH) VERSUS HUMAN MENOPAUSAL GONADOTROPIN (U-HMG) IN ASSISTED REPRODUCTIVE TECHNOLOGY (ART): A STUDY BASED ON GERMAN REAL-WORLD DATA.
    Buehler, Klaus F.
    Guedes, Sandra
    Allignol, Arthur
    D'Hooghe, Thomas
    Bilger, Wilma
    Boutmy, Emmanuelle
    Richter, Emilia
    Fischer, Robert
    [J]. FERTILITY AND STERILITY, 2019, 112 (03) : E194 - E194
  • [30] Controlled ovarian stimulation with recombinant follicle-stimulating hormone provides better outcomes than urinary gonadotropins for patients undergoing assisted reproductive technologies
    Scheiber, MD
    Behnke, EJ
    Awadalla, SG
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : S235 - S235